Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bode Chemie, originally established as Bacillolfabrik Dr. Bode & Co, is a prominent German manufacturer specializing in disinfection, hygiene, and skin protection products. Founded in 1924, the company gained international recognition for developing Bacillol, one of the first rapid surface disinfectants, and Sterillium, the first marketable alcohol-based hand disinfectant. The company's portfolio focuses on infection prevention solutions, including hand and skin antisepsis, surface disinfection, and instrument reprocessing for the healthcare and industrial sectors. Since 1993, Bode Chemie has operated as a core subsidiary of the HARTMANN GROUP, leveraging a global distribution network to provide hygiene solutions. Their research and development efforts are centered on the BODE Science Center, which focuses on improving patient safety and hygiene compliance through evidence-based practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bacillolfabrik Dr. Bode & Co.